05.03.16
Quintiles
1Q Revenues: $1.5 billion (+11%)
1Q Earnings: $109 million (+26%)
Comments: Net new business was $1.03 billion in the quarter, representing a book-to-bill ratio of 0.93. The Product Development segment new business totaled $799 million, up 12% driven by Q2 Solutions and volume-related increases in core clinical services and clinical trial support services, offset by a decline in advisory services and negatively impacted by $6.9 million of unfavorable foreign currency fluctuations. The Integrated Healthcare Services segment net new business totaled $227 million, down 3% from unfavorable foreign currency fluctuations.
1Q Revenues: $1.5 billion (+11%)
1Q Earnings: $109 million (+26%)
Comments: Net new business was $1.03 billion in the quarter, representing a book-to-bill ratio of 0.93. The Product Development segment new business totaled $799 million, up 12% driven by Q2 Solutions and volume-related increases in core clinical services and clinical trial support services, offset by a decline in advisory services and negatively impacted by $6.9 million of unfavorable foreign currency fluctuations. The Integrated Healthcare Services segment net new business totaled $227 million, down 3% from unfavorable foreign currency fluctuations.
